Welcome!

The following guide is intended to help people with multiple myeloma (MM), their caregivers, friends, and family learn about clinical trials and how they measure their purposes, called endpoints, like overall survival or changes in quality of life. Learning this information can help you better understand clinical data shared through conferences, press releases, news articles, and by your healthcare team. It could also help you when selecting a clinical trial for yourself. 

What to find in this guide

Throughout the guide, we will explain the basic information about clinical trials, review different clinical trial endpoints and why they matter, and include questions to ask your doctors if you’re interested in participating in one.

Developed independently by HealthTree, this guide has been reviewed by medical experts and myeloma patients and caregivers to ensure accuracy and relevance to you.

What you won't find here

This guide won't delve into the general aspects of multiple myeloma and its diagnosis, nor will it explore a comprehensive list of all myeloma treatments and clinical trials.

For foundational information about multiple myeloma, its progression, response criteria, or a deep dive into multiple myeloma clinical trials, we recommend exploring our rich library of resources:

• Multiple Myeloma 101
• HealthTree University
• HealthTree Myeloma News
• HealthTree Myeloma Webinars
• HealthTree Myeloma Clinical Trial Finder

How to navigate the guide 

Because this guide is comprehensive, it’s not expected to be read all at once. We invite you to use the side navigation panel to find different sections and use the left and right arrows on each page to browse the information within each section.

If you are on a mobile device, click the horizontal lines icon near the top right of your screen in order to find the navigation panel. 

Keeping up-to-date

The field of myeloma clinical trial research is continuously evolving. While we strive to keep this guide updated with the latest information, some data and approval statuses may not reflect all recent developments. The guide is timestamped to show the last time the information was updated. It will be updated routinely to ensure accuracy on the subject.

Remember

This guide is intended to help you better understand clinical trial data, press releases about clinical trials, and understand your clinical trial options, but should never replace conversations with your medical team. Always discuss your questions or concerns about multiple myeloma clinical trials or your specific treatment plan with your doctor.

Thank you to our sponsors: